Eli Lilly‘s Symbyax finally approved for depression – Eli Lilly has received approval from the U.S. Food and Drug Administration for use of a combo pill called Symbyax to treat treatment-resistant depression. “Until today, there has been no approved medication for treatment-resistant depression,” said Lilly Medical Director Dr. Sara Corya. “Now, after two failed attempts with other antidepressants, doctors and patients have a new treatment option.”
Nycomed: another one up for sale?
The long decline of drug sales reps: a quick summary from the WSJ about some of the data coming out recently.
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff